Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Biol Reprod ; 90(2): 40, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24451983

RESUMO

Approximately 30% of infants in the United States are exposed to high doses of isoflavones resulting from soy infant formula consumption. Soybeans contain the isoflavones genistin and daidzin, which are hydrolyzed in the gastrointestinal tract to their genistein and daidzein aglycones. Both aglycones possess hormonal activity and may interfere with male reproductive development. Testosterone, which supports male fertility, is mainly produced by testicular Leydig cells. Our previous studies indicated that perinatal exposure of male rats to isoflavones induced proliferative activity in Leydig cells and increased testosterone concentrations into adulthood. However, the relevance of the neonatal period as part of the perinatal window of isoflavone exposure remains to be established. The present study examined the effects of exposure to isoflavones on male offspring of dams maintained on a casein-based control or whole soybean diet in the neonatal period, that is, Days 2 to 21 postpartum. The results showed that the soybean diet stimulated proliferative activity in developing Leydig cells while suppressing their steroidogenic capacity in adulthood. In addition, isoflavone exposure decreased production of anti-Müllerian hormone by Sertoli cells. Similar to our previous in vitro studies of genistein action in Leydig cells, daidzein induced proliferation and interfered with signaling pathways to suppress steroidogenic activity. Overall, the data showed that the neonatal period is a sensitive window of exposure to isoflavones and support the view that both genistein and daidzein are responsible for biological effects associated with soy-based diets.


Assuntos
Dieta , Alimentos de Soja/toxicidade , Testículo/crescimento & desenvolvimento , Animais , Animais Recém-Nascidos , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Dieta/efeitos adversos , Feminino , Genisteína/farmacologia , Hormônios Esteroides Gonadais/biossíntese , Isoflavonas/farmacologia , Células Intersticiais do Testículo/citologia , Células Intersticiais do Testículo/efeitos dos fármacos , Células Intersticiais do Testículo/fisiologia , Masculino , Gravidez , Ratos , Ratos Long-Evans , Testículo/citologia , Testículo/efeitos dos fármacos
2.
Biol Reprod ; 83(3): 488-501, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20554919

RESUMO

Testicular Leydig cells, which are the predominant source of the male sex steroid hormone testosterone, express estrogen receptors (ESRs) and are subject to regulation by estrogen. Following ingestion, the two major isoflavones in soybeans, genistin and daidzin, are hydrolyzed by gut microflora to form genistein and daidzein, which have the capacity to bind ESRs and affect gene expression. Thus, the increasing use of soy-based products as nondairy sources of protein has raised concerns about the potential of these products to cause reproductive toxicity. In the present study, perinatal exposure of male rats to isoflavones induced proliferative activity in Leydig cells. Isoflavones have the capacity to act directly as mitogens in Leydig cells, because genistein treatment induced Leydig cell division in vitro. Genistein action regulating Leydig cell division involved ESRs, acting in concert with signaling molecules in the transduction pathway mediated by protein kinase B (AKT) and mitogen-activated protein kinase (MAPK). Enhanced proliferative activity in the prepubertal period increased Leydig cell numbers, which alleviated deficits in androgen biosynthesis and/or augmented serum and testicular testosterone concentrations in adulthood. Together, these observations indicate that the perinatal exposures of male rats to isoflavones affected Leydig cell differentiation, and they imply that including soy products in the diets of neonates has potential implications for testis function.


Assuntos
Diferenciação Celular/efeitos dos fármacos , Glycine max , Isoflavonas/farmacologia , Células Intersticiais do Testículo/efeitos dos fármacos , Análise de Variância , Animais , Animais Recém-Nascidos , Western Blotting , Proliferação de Células/efeitos dos fármacos , Estradiol/biossíntese , Imuno-Histoquímica , Células Intersticiais do Testículo/metabolismo , Masculino , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Ratos , Ratos Long-Evans , Receptores Androgênicos/metabolismo , Receptores do LH/metabolismo , Transdução de Sinais/efeitos dos fármacos , Testosterona/biossíntese
3.
Toxicol Lett ; 184(3): 169-75, 2009 Feb 10.
Artigo em Inglês | MEDLINE | ID: mdl-19059320

RESUMO

Testicular Leydig cells express estrogen receptors and are the predominant source of the male sex steroid hormone testosterone (T). Previous studies demonstrated that genistein acts through estrogen receptors in Leydig cells. In the present study, pre-treatment of Leydig cells isolated from 35 day-old male Long Evans rats with the epidermal growth factor receptor (EGFR) kinase inhibitor AG 1478 abrogated genistein inhibition of T biosynthesis. Also, incubation of Leydig cells in culture medium containing epidermal growth factor (EGF) decreased T secretion (control: 255+/-16; EGF: 190+/-17ng/10(6) cells, 24h) (P<0.05). However, T secretion by genistein-treated Leydig cells (0.1nM, 10muM; 24h) was rescued by post-treatment incubation with forskolin (control: 275+/-28 versus 325+/-35; 780+/-85; ng/10(6) cells, 3h) and dibutyryl cyclic adenosine 3'-5'-monophosphate (dbcAMP) (control: 370+/-65 versus 580+/-75; 2500+/-200; ng/10(6) cells, 3h) (P>0.05). Furthermore, post-treatment incubation with cholera toxin, an activator of G proteins, caused genistein-treated Leydig cells to produce similar T amounts as untreated control (control: 55+/-5 versus 52+/-2 and 47+/-4; ng/10(6) cells, 3h) (P>0.05). These observations imply that genistein action interferes with coupling of transmembrane luteinizing hormone receptors (LHR) with G proteins. Uncoupling of LHR from G proteins adversely affects adenylate cyclase function and impacts LH-dependent stimulation of Leydig cells. These findings have implications for testicular steroidogenesis in individuals exposed to genistein and soy-based products.


Assuntos
Disruptores Endócrinos/toxicidade , Genisteína/toxicidade , Células Intersticiais do Testículo/efeitos dos fármacos , Hormônio Luteinizante/metabolismo , Transdução de Sinais/efeitos dos fármacos , Testosterona/biossíntese , Adenilil Ciclases/metabolismo , Animais , Células Cultivadas , Toxina da Cólera/farmacologia , Colforsina/farmacologia , CMP Cíclico/análogos & derivados , CMP Cíclico/farmacologia , Relação Dose-Resposta a Droga , Regulação para Baixo , Ativadores de Enzimas/farmacologia , Fator de Crescimento Epidérmico/metabolismo , Receptores ErbB/efeitos dos fármacos , Receptores ErbB/metabolismo , Células Intersticiais do Testículo/enzimologia , Células Intersticiais do Testículo/metabolismo , Masculino , Inibidores de Proteínas Quinases/farmacologia , Quinazolinas , Ratos , Ratos Long-Evans , Receptores do LH/efeitos dos fármacos , Receptores do LH/metabolismo , Tirfostinas/farmacologia
4.
Complement Ther Med ; 47: 102206, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31780035

RESUMO

Morinda citrifolia (Noni) is a popular traditional medicinal plant consumed in various forms in several countries around the world as a complementary and alternative treatment due to its established health benefits. Noni is rich in bioactive substances and has significantly exhibited pro-oxidant and immunomodulatory effects. In this review, we highlight the pharmacological basis related to the phytochemicals and polysaccharides present in Noni and its potential therapeutic effects. We screened electronic databases such as PubMed, Google Scholar, Scopus for scientific literature. Our results indicate that Noni is beneficial for various diseases with its crude extracts showing therapeutic benefit for a wide range of pathological diseases. We believe that further pharmacological and toxicological studies in addition to well-designed controlled clinical trials can validate Noni to be an effective and novel natural product for prophylactic and therapeutic use of several diseases.


Assuntos
Medicamentos de Ervas Chinesas/uso terapêutico , Sistema Imunitário/efeitos dos fármacos , Morinda/química , Extratos Vegetais/imunologia , Extratos Vegetais/uso terapêutico , Humanos , Polinésia
5.
Endocrinology ; 148(9): 4475-88, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17569756

RESUMO

The use of soy-based products in the diet of infants has raised concerns regarding the reproductive toxicity of genistein and daidzein, the predominant isoflavones in soybeans with estrogenic activity. Time-bred Long-Evans dams were fed diets containing 0, 5, 50, 500, or 1000 ppm of soy isoflavones from gestational d 12 until weaning at d 21 postpartum. Male rats in all groups were fed soy-free diets from postnatal d 21 until 90 d of age. The mean +/- SD concentration of unconjugated (i.e. biologically active) genistein and daidzein in serum from the group of dams maintained on the diet containing the highest amount of isoflavones (1000 ppm) were 17 +/- 27 and 56 +/- 30 nM, respectively, at d 21 postpartum. The concentrations were considerably greater in male offspring (genistein: 73 +/- 46 nM; daidzein: 106 +/- 53 nM). Although steroidogenesis was decreased in individual Leydig cells, male rats from the highest exposure group (1000 ppm diet) exhibited elevated serum levels of the sex steroid hormones androsterone at 21 d (control: 15 +/- 1.5 vs.28 +/- 3.5 ng/ml; P < 0.05) and testosterone at 90 d of age (control: 7.5 +/- 1 vs.17 +/- 2 ng/ml; P < 0.05). Testosterone secretion by immature Leydig cells, isolated from 35-d-old male rats, decreased on exposure to 0.1 nm genistein in vitro (control: 175 +/- 5 vs. 117 +/- 3 ng/10(6) cells per 24 h; P < 0.05), indicative of direct phytoestrogen action. Thus, phytoestrogens have the ability to regulate Leydig cells, and additional studies to assess potential adverse effects of dietary soy-based products on reproductive tract development in neonates are warranted.


Assuntos
Androgênios/metabolismo , Isoflavonas/farmacologia , Células Intersticiais do Testículo/metabolismo , Fitoestrógenos/farmacologia , Testículo/embriologia , Animais , Feminino , Idade Gestacional , Células Intersticiais do Testículo/efeitos dos fármacos , Masculino , Gravidez , Ratos , Ratos Long-Evans , Suínos , Testículo/efeitos dos fármacos
6.
Artigo em Inglês | MEDLINE | ID: mdl-14581076

RESUMO

The development and validation of a high-performance liquid chromatographic and UV detection method was accomplished for quantitative determination of levamisole in chicken tissues, eggs and plasma. The chromatographic separation was achieved on Luna 5 microm C(18) column using a mobile phase of 0.2% acetic acid in water:methanol (50:50 (v/v)) and Pic B-7 low UV reagent and the pH was adjusted to 7.31 with ammonium hydroxide and UV wavelength was 225 nm. Limits of quantification were 0.025 microg/g for all tissues and 0.003 microg/ml for plasma. Limit of detection was 0.001 microg/g for tissues and plasma.


Assuntos
Anti-Helmínticos/análise , Cromatografia Líquida de Alta Pressão/métodos , Levamisol/análise , Espectrofotometria Ultravioleta/métodos , Animais , Anti-Helmínticos/sangue , Anti-Helmínticos/farmacocinética , Galinhas , Levamisol/sangue , Levamisol/farmacocinética , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Distribuição Tecidual
7.
Int J Pharm ; 271(1-2): 301-3, 2004 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-15129998

RESUMO

The penetration of dazmegrel, a selective thromboxane synthetase inhibitor, through excised human and greyhound skin was measured. A bioelastic matrix was used for topical delivery. Results demonstrated that dazmegrel readily penetrated the skin. Penetration through greyhound skin was significantly greater than penetration through human skin. Penetration through greyhound skin was not significantly different between 4, 24, and 48 h of exposure for the low and intermediate doses studied.


Assuntos
Inibidores Enzimáticos/farmacocinética , Imidazóis/farmacocinética , Absorção Cutânea , Animais , Cães , Humanos , Técnicas In Vitro , Permeabilidade
8.
Nat Prod Commun ; 8(10): 1415-8, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24354189

RESUMO

Scutellaria lateriflora (American skullcap), a native plant of North America, has been used by Americans and Europeans as a nerve tonic for more than 200 years. In vivo studies have shown anxiolytic activity ofS. lateriflora in animals and humans. However, the neuroprotective mechanisms ofS. lateriflora are not fully understood. Oxidative stress plays a vital role in the neurodegenerative and neuropsychiatric diseases such as anxiety, Alzheimer's disease, depression, and Parkinson's disease. Bioactive compounds present in various medicinal plants neutralize or scavenge toxic free radicals and thus suppress oxidative stress. Therefore, the objective of this study was to investigate the antioxidant effects of S. lateriflora. The antioxidant potential of aqueous or ethanolic extracts of S. lateriflora was determined in mouse brain tissue using various biochemical assays. Protective effects of S. lateriflora against oxidative stress induced DNA fragmentation was determined using plasmid DNA. The ethanolic and aqueous extracts scavenged the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals. The ethanolic extract reduced tert-butyl peroxide-induced reactive oxygen species (ROS) and lipid peroxides in the mouse brain homogenates. Furthermore, the ethanolic extract of S. lateriflora protected hydrogen peroxide-UV induced cleavage of supercoiled plasmid DNA. In conclusion, S. lateriflora exhibited significant antioxidant effects. The current findings posit S. lateriflora as one of the potential experimental herbal drugs that should be screened for its therapeutic potential against various oxidative stress associated mental disorders.


Assuntos
Antioxidantes/análise , Fármacos Neuroprotetores/análise , Estresse Oxidativo/efeitos dos fármacos , Scutellaria/química , Animais , Antioxidantes/farmacologia , Encéfalo/metabolismo , Fragmentação do DNA/efeitos dos fármacos , Peroxidação de Lipídeos/efeitos dos fármacos , Camundongos , Fármacos Neuroprotetores/farmacologia , Plantas Medicinais/química
9.
Wound Repair Regen ; 12(4): 453-60, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15260811

RESUMO

A previous study showed that topical exposure to bioelastic-thromboxane synthetase inhibitor-matrix resulted in local tissue concentrations of thromboxane synthetase inhibitor sufficient for thromboxane synthetase inhibition. The objective of this research was to use an animal model to determine if a dressing having controlled release of thromboxane synthetase inhibitor (dazmegrel) could be used to prevent tissue breakdown over pressure points, i.e., lesion at the assistive device-skin interface. The animal model studies utilized the greyhound, a dog that has thin skin, angular conformation, limited body fat and is predisposed to pressure ulcers similar to those occurring in humans. The model uses a short-limb walking cast on one pelvic limb with the severity of the dermal pressure lesions induced over the medial malleolus controlled by the amount of padding in the cast and length of time the cast is in place. The bioelastic matrix loaded with dazmegrel provided protection from shearing and pressure skin injury over the medial malleolus, as evidenced by a decrease in epidermal abrasion/ulceration as measured with planimetry. Histopathologic evaluation of the skin over the medial malleolus indicated a protective function of the bioelastic matrix as measured as lower numbers of neutrophils, lymphocytes, and decreased collagen density compared to such numbers when no bioelastic matrix was present. These studies provided evidence that bioelastic-thromboxane sythetase inhibitor- matrix helps in preventing or reducing the severity of pressure lesions, e.g., assistive device-skin interface wounds.


Assuntos
Bandagens , Inibidores Enzimáticos/administração & dosagem , Imidazóis/administração & dosagem , Úlcera por Pressão/prevenção & controle , Tromboxano-A Sintase/antagonistas & inibidores , Administração Tópica , Animais , Cães , Elasticidade , Hiperemia/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA